RNS Number: 1851 F Official List 06 March 2020. This notice has been issued by Issuer Management- 020 7066 8352.. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
On 4 February 2020, the boards of Recipharm Holdings Limited and Consort Medical plc announced that the recommended cash offer to acquire the entire issued and to be issued share capital of Consort had been declared unconditional in all respects. Further to the announcement made by Recipharm and Consort on 6 February 2020 that Consort would apply to the UK...
RNS Number: 7229 E Consort Medical PLC 02 March 2020. The Company hereby notifies the market of the following disclosure with respect to the share capital and voting rights of the Company:. As at 29 February 2020, the capital of the Company consists of 49,960,574 ordinary shares of 10 pence each with voting rights.
On 4 February 2020, the boards of Recipharm Holdings Limited and Consort Medical plc announced that the recommended cash offer to acquire the entire issued and to be issued share capital of Consort had been declared unconditional in all respects. As at 3.00 p.m. on 19 February 2020, Recipharm owns, or has received valid acceptances of the Offer, in respect of a...
RNS Number: 2595 D Recipharm AB 17 February 2020 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION. a directly wholly-owned subsidiary of Recipharm AB.
Recipharm Holdings Limited, a wholly owned subsidiary of Recipharm AB, is pleased to announce that it now owns or has received valid acceptances in respect of a total of 37,906,222 Consort Medical plc Shares representing approximately 75.9 per cent. of the existing issued share capital of Consort.. As set out in paragraph 14 of Part 2 of the offer document posted...
RNS Number: 2564 C Consort Medical PLC 06 February 2020. Notification and public disclosure by persons discharging managerial responsibilities. Acquisition of entire issued and to be issued share capital of the Company by Recipharm Holdings Limited, a wholly-owned direct subsidiary of Recipharm AB, by way of a recommended cash offer- exercise of share...
RNS Number: 2359 C Consort Medical PLC 06 February 2020 TR-1: S tandard form for notification of major holdings. i Please note that national forms may vary due to specific national legislation as for instance the applicable thresholds or information regarding capital holdings.. Indicate in the relevant section whether the issuer is a non UK issuer..
RNS Number: 0834 C FTSE Russell 05 February 2020. Consort Medical: Constituent Deletion Changes in FTSE UK Index Series. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 1164 C Consort Medical PLC 05 February 2020 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
As at 1.00 p.m. on 4 February 2020, being the acceptance deadline, Recipharm had received valid acceptances of the Offer in respect of a total of 30,854,661 Consort Shares representing 62.5 per cent. of the existing issued share capital of Consort, which Recipharm may count towards the satisfaction of the acceptance condition of the Offer, as set out in Part A of...
RNS Number: 6333 B Consort Medical PLC 03 February 2020. Application has been made to the UK Listing Authority and the London Stock Exchange for a listing of 366,863 Ordinary Shares of 10 pence each to be admitted to the Official List. The Shares are to be issued to satisfy the exercise of options under the Company's 2015 Performance Share Plans, and the listing...
RNS Number: 3422 B Consort Medical PLC 29 January 2020 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 3040 B Consort Medical PLC 29 January 2020 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION. The Board of Consort notes today's announcement by...
RNS Number: 2860 B Consort Medical PLC 29 January 2020 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 2245 B Recipharm AB 29 January 2020 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. On 6 December 2019, Recipharm published an offer document setting out the full terms and conditions of its...
RNS Number: 9935 A Consort Medical PLC 27 January 2020 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 9934 A Consort Medical PLC 27 January 2020 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 9933 A Consort Medical PLC 27 January 2020 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 9140 A Recipharm AB 24 January 2020 FORM 8. AMENDMENT- THIS FORM REPLACES RNS NUMBER: 7495 A. CHANGES MADE TO SECTION 3.
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    49.36M

Classification

Market Indices-

Locations

HQ
Breakspear Park
Breakspear Way
Ground Floor, Suite D
Hemel Hempstead
HP2 4TZ
Watchlist